Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.43.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.332NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.100NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.43.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.66NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.19.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.479NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.437NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.371NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JS.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HG.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.108NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.104NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used